• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊收缩素启动子多态性(CCK - 36CT)与惊恐障碍之间可能存在的关联。

Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder.

作者信息

Wang Z, Valdes J, Noyes R, Zoega T, Crowe R R

机构信息

Department of Psychiatry, University of Iowa College of Medicine, Iowa City 52242-1000, USA.

出版信息

Am J Med Genet. 1998 May 8;81(3):228-34. doi: 10.1002/(sici)1096-8628(19980508)81:3<228::aid-ajmg5>3.0.co;2-s.

DOI:10.1002/(sici)1096-8628(19980508)81:3<228::aid-ajmg5>3.0.co;2-s
PMID:9603610
Abstract

We searched for mutations in the CCK gene in panic disorder with single-strand conformational polymorphism (SSCP) analysis of the three exons and promotor region of the gene. We found a C-->T transition at position -36 (CCK(-36C-->T)) in a GC box, a binding site for transcription factor Sp1, in the promotor region. The allele frequency was 0.168 (95% CI, 0.116-0.221) in 98 persons with panic disorder and 0.083 (95% CI, 0.059-0.107) in 247 geographically matched, unscreened controls. A transmission disequilibrium test based on panic disorder as the affected phenotype was nonsignificant (chi2 = 0.93), but when panic disorder or attacks were considered as affected, statistically significant transmission disequilibrium was detected (chi2 = 4.00, P < 0.05). Linkage analysis was uninformative. In exploratory analyses to search for clinical correlations, the "T" allele was found in 59% of 22 persons with panic attacks but not panic disorder, compared with 31% of those who met the criteria for panic disorder. An association between the CCK polymorphism and panic disorder cannot be considered established due to the inconsistencies in the results noted above, but if the provisional association can be replicated, the findings are consistent with CCK(-36C-->T) being a disease-susceptibility allele that alone is neither necessary nor sufficient to cause panic disorder but that increases vulnerability by acting epistatically.

摘要

我们通过对胆囊收缩素(CCK)基因的三个外显子和启动子区域进行单链构象多态性(SSCP)分析,来寻找惊恐障碍患者中该基因的突变。我们在启动子区域的一个GC盒(转录因子Sp1的结合位点)中发现了一个位于-36位的C→T转换(CCK(-36C→T))。在98名惊恐障碍患者中,该等位基因频率为0.168(95%可信区间,0.116 - 0.221),而在247名地理匹配的未筛选对照中为0.083(95%可信区间,0.059 - 0.107)。以惊恐障碍为受影响表型的传递不平衡检验无统计学意义(χ2 = 0.93),但当将惊恐障碍或惊恐发作视为受影响时,检测到有统计学意义的传递不平衡(χ2 = 4.00,P < 0.05)。连锁分析无信息价值。在寻找临床相关性的探索性分析中,在22名有惊恐发作但无惊恐障碍的患者中,59%发现了“T”等位基因,而符合惊恐障碍标准的患者中这一比例为31%。由于上述结果存在不一致性,因此不能认为CCK基因多态性与惊恐障碍之间存在关联,但如果这种初步关联能够被重复验证,那么这些发现与CCK(-36C→T)是一种疾病易感性等位基因相一致,该等位基因单独既不是导致惊恐障碍的必要条件也不是充分条件,但通过上位作用增加了易感性。

相似文献

1
Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder.胆囊收缩素启动子多态性(CCK - 36CT)与惊恐障碍之间可能存在的关联。
Am J Med Genet. 1998 May 8;81(3):228-34. doi: 10.1002/(sici)1096-8628(19980508)81:3<228::aid-ajmg5>3.0.co;2-s.
2
Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder.惊恐障碍中胆囊收缩素及胆囊收缩素B受体基因多态性
J Neural Transm Suppl. 2004(68):147-56. doi: 10.1007/978-3-7091-0579-5_17.
3
Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder.胆囊收缩素B受体基因的错义突变:与惊恐障碍无关。
Am J Med Genet. 1996 Jul 26;67(4):401-5. doi: 10.1002/(SICI)1096-8628(19960726)67:4<401::AID-AJMG14>3.0.CO;2-N.
4
Identification of a compound short tandem repeat stretch in the 5'-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia.胆囊收缩素基因5'-上游区域复合短串联重复序列片段的鉴定及其与惊恐障碍而非精神分裂症的关联。
Mol Psychiatry. 2001 Jul;6(4):465-70. doi: 10.1038/sj.mp.4000875.
5
No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder.编码胆囊收缩素的基因多态性与胆囊收缩素B受体之间不存在关联或连锁关系,且与惊恐障碍无关。
Mol Psychiatry. 2001 Jan;6(1):59-65. doi: 10.1038/sj.mp.4000788.
6
Investigation of cholecystokinin system genes in panic disorder.惊恐障碍中胆囊收缩素系统基因的研究。
Mol Psychiatry. 1999 May;4(3):284-5. doi: 10.1038/sj.mp.4000507.
7
Possible association of a cholecystokinin promoter variant to schizophrenia.
Am J Med Genet. 2002 Jul 8;114(5):479-82. doi: 10.1002/ajmg.10408.
8
Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.在健康志愿者中使用CCK - 4激发试验对惊恐障碍候选基因进行关联测试。
Neurosci Lett. 2008 Dec 3;446(2-3):88-92. doi: 10.1016/j.neulet.2008.09.052.
9
Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese.日本人群中胆囊收缩素A受体基因多态性与惊恐障碍的关联
Am J Med Genet B Neuropsychiatr Genet. 2004 May 15;127B(1):78-80. doi: 10.1002/ajmg.b.20160.
10
Gene variations in the cholecystokinin system in patients with panic disorder.惊恐障碍患者胆囊收缩素系统的基因变异
Psychiatr Genet. 2010 Apr;20(2):59-64. doi: 10.1097/YPG.0b013e32833511a8.

引用本文的文献

1
Cholecystokinin and Panic Disorder: Reflections on the History and Some Unsolved Questions.胆囊收缩素与惊恐障碍:历史反思与未解问题探讨。
Molecules. 2021 Sep 17;26(18):5657. doi: 10.3390/molecules26185657.
2
Personality neuroscience and psychopathology: should we start with biology and look for neural-level factors?人格神经科学与精神病理学:我们应该从生物学入手并寻找神经层面的因素吗?
Personal Neurosci. 2020 May 5;3:e4. doi: 10.1017/pen.2020.5. eCollection 2020.
3
Some Metatheoretical Principles for Personality Neuroscience.人格神经科学的一些元理论原则。
Personal Neurosci. 2018 Aug 10;1:e11. doi: 10.1017/pen.2018.9. eCollection 2018.
4
Exploring the association between a cholecystokinin promoter polymorphism (rs1799923) and posttraumatic stress disorder in combat veterans.探索胆囊收缩素启动子多态性(rs1799923)与退伍军人创伤后应激障碍之间的关联。
J Anxiety Disord. 2015 Dec;36:78-83. doi: 10.1016/j.janxdis.2015.09.009. Epub 2015 Sep 28.
5
Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.惊恐障碍的候选基因:主要焦虑途径中 23 个常见变异的荟萃分析。
Mol Psychiatry. 2016 May;21(5):665-79. doi: 10.1038/mp.2015.138. Epub 2015 Sep 22.
6
The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders.5-羟色胺能和 GABA 能系统在焦虑障碍药物研发转化方法学中的作用。
Front Pharmacol. 2013 Jun 11;4:74. doi: 10.3389/fphar.2013.00074. eCollection 2013.
7
The genetic basis of panic disorder.惊恐障碍的遗传学基础。
J Korean Med Sci. 2011 Jun;26(6):701-10. doi: 10.3346/jkms.2011.26.6.701. Epub 2011 May 18.
8
Gastrin: old hormone, new functions.胃泌素:旧激素,新功能。
Pflugers Arch. 2005 Jan;449(4):344-55. doi: 10.1007/s00424-004-1347-5. Epub 2004 Oct 5.
9
Genetic animal models of anxiety.焦虑症的基因动物模型。
Neurogenetics. 2003 Apr;4(3):109-35. doi: 10.1007/s10048-003-0143-2. Epub 2003 Mar 29.
10
Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon.缺乏蛋白激酶Cε的小鼠焦虑样行为减少、应激激素降低以及神经甾体超敏反应。
J Clin Invest. 2002 Oct;110(7):1003-10. doi: 10.1172/JCI15903.